At the Foot and Ankle Center of Arizona, my team and I are committed to providing the latest in pain management. As a board-certified foot and ankle surgeon, I, Dr. Kris A. DiNucci, DPM, FACFAS, understand the need for proper pain management, especially for ICU patients. This article explores the new use of lidocaine as an ICU replacement for opioid therapy.
Lidocaine is a time-tested local anesthetic, which was originally used in topical forms and localized injections. Its use has been extended to intravenous lidocaine infusion (IVLI), especially in ICU patients. My interest in the use of lidocaine as a pain management tool is due to its role in lowering opioid intake and, thus, eliminating the unwanted effects of opioids like respiratory depression and dependency.
A pivotal study by Yoon Sun Mo, Pharm.D., and colleagues highlights the efficacy of intravenous lidocaine in managing pain for critically ill patients. Published in the Journal of Clinical Pharmacology on February 7, 2017, this study underscores IVLI’s potential to improve pain management in ICU settings, particularly for patients with varying degrees of organ dysfunction.
A review of 21 ICU patients from two hospitals provided valuable information about intravenous lidocaine efficacy and safety.
Study Highlights:
Rapid Relief of Pain: The patients showed a ≥20% decrease in pain score within a mean of 3.3 hours from the start of IVLI.
Opioid Use Reduced: Median morphine dose equivalents were significantly reduced after IVLI:
Minimal Adverse Effects: Neurological side effects were reported by only three patients, which disappeared after stopping IVLI.
This study supports some of the most important advantages of intravenous lidocaine:
Opioid Alternative: IVLI provides an adequate alternative for patients who do not respond to opioids or are prone to opioid-induced respiratory depression.
Although intravenous lidocaine provides high benefits, administration and observation must be performed cautiously:
At the Foot and Ankle Center of Arizona, I am in charge of a team of dedicated professionals who are dedicated to using advanced pain management techniques. With extensive experience in my field of practice, I personally see to it that all patients are given personalized attention and access to the most superior care for pain relief. My specialty is providing the best mode of treatment to patients with acute and chronic pain.
The more that is known, the more intravenous lidocaine could potentially become a routine substitute for conventional pain management in critical care cases. Its potential to revolutionize pain control positions it to be a valuable tool for maximizing patient outcomes while reducing the country’s dependence on opioids.
The use of lidocaine in pain management, particularly for application in the ICU setting, represents a new positive development in the treatment regimens. For patients of my facility, Foot and Ankle Center of Arizona, I remain at the forefront of using novel methods to obtain relief for the health requirements of my clients in Scottsdale, AZ.
For more information regarding advanced pain management solutions, I encourage you to reach out to my professional team at the Foot and Ankle Center of Arizona today.